Prostaglandin E2 in intestinal secretion with special reference to methodological problems in vivo and in vitro.
Bukhave
K
K
Department of Medical Gastroenterology, Herlev Hospital, Copenhagen.
D000236:Adenoma / Q000378:metabolism; D000818:Animals; D002771:Cholera / Q000378:metabolism; D003109:Colonic Diseases, Functional / Q000378:metabolism; D003967:Diarrhea / Q000139:chemically induced / Q000378:metabolism; D015232:Dinoprostone / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004381:Duodenal Ulcer / Q000378:metabolism; D004573:Electrolytes / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007419:Intestinal Secretions / Q000737:chemistry; D007583:Jejunum / Q000187:drug effects / Q000378:metabolism; D009020:Morphine; D011817:Rabbits; D051381:Rats; D012004:Rectal Neoplasms / Q000378:metabolism; D012701:Serotonin / Q000494:pharmacology; D013375:Substance Withdrawal Syndrome / Q000378:metabolism
D004573:Electrolytes; D012701:Serotonin; D009020:Morphine; D015232:Dinoprostone; D007213:Indomethacin